BackRegenxbio Overview

Regenxbio Net Tangible Assets

Track Regenxbio's net tangible assets ($72M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$71.77M
66.41% YoYΔ $-141.91M vs prior year quarter

Peer trimmed avg / median

Loading

Regenxbio Net Tangible Assets History

Loading

Regenxbio vs. peers: Net Tangible Assets Comparison

Loading

Regenxbio Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Regenxbio (RGNX) FAQ

Regenxbio (RGNX) currently reports a net tangible assets of $72M as of June 2026. That compares with $210M in the prior-year period — down 66.4% year over year. Use the charts on this page to explore Regenxbio's net tangible assets history and peer comparisons.

Regenxbio's net tangible assets decreased from $210M to $72M — a 66.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Regenxbio reported $72M in net tangible assets as of June 2026. That compares with $210M in the prior-year period — down 66.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $72M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Regenxbio, and consider following RGNX for alerts when major investors trade the stock.

Regenxbio is classified in the Healthcare sector. On net tangible assets, it currently shows $72M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RGNX with unrelated industries.